[1] |
SUN J, ROELSTRAETE B, SVENNBERG E, et al. Long-term risk of arrhythmias in patients with inflammatory bowel disease: a population-based, sibling-controlled cohort study[J]. PLoS Med, 2023, 20(10):e1004305. doi: 10.1371/journal.pmed.1004305 |
[2] |
刘飞艳, 杨浩. 胃肠道疾病与心房颤动的相关性研究[J]. 齐齐哈尔医学院学报, 2020, 41(14):1793-1797. doi: 10.3969/j.issn.1002-1256.2020.14.032 |
[3] |
ZUIN M, ZULIANI G, RIGATELLI G, et al. Atrial fibrillation in patients with inflammatory bowel disease: a systematic review and meta-analysis[J]. Eur J Intern Med, 2020, 76:120-122. doi: 10.1016/j.ejim.2020.02.029 |
[4] |
TILLY M J, GEURTS S, ZHU F, et al. Autoimmune diseases and new-onset atrial fibrillation: a UK Biobank study[J]. Europace, 2023, 25(3):804-811. doi: 10.1093/europace/euac244 |
[5] |
KRISTENSEN S L, LINDHARDSEN J, AHLEHOFF O, et al. Increased risk of atrial fibrillation and stroke during active stages of inflammatory bowel disease: a nationwide study[J]. Europace, 2014, 16(4):477-484. doi: 10.1093/europace/eut312 |
[6] |
CHOI Y J, CHOI E K, HAN K D, et al. Increased risk of atrial fibrillation in patients with inflammatory bowel disease: a nationwide population-based study[J]. World J Gastroenterol, 2019, 25(22):2788-2798. doi: 10.3748/wjg.v25.i22.2788 |
[7] |
OLIVERA P A, ZUILY S, KOTZE P G, et al. International consensus on the prevention of venous and arterial thrombotic events in patients with inflammatory bowel disease[J]. Nat Rev Gastroenterol Hepatol, 2021, 18(12):857-873. doi: 10.1038/s41575-021-00492-8 |
[8] |
CAN G, EKMEN N, CAN H, et al. Is there any link between atrial arrhythmias and inflammatory bowel disease?[J]. Saudi J Gastroenterol, 2021, 27(5):289-295. doi: 10.4103/sjg.sjg_622_20 |
[9] |
RAHMAN E U, GAYAM V, GARLAPATI P, et al. Association of atrial fibrillation with outcomes in patients hospitalized with inflammatory bowel disease: an analysis of the National Inpatient Sample[J]. Arch Med Sci Atheroscler Dis, 2021, 6:e40-e47. doi: 10.5114/amsad.2021.105256 |
[10] |
JOO M K, PARK C H, KIM J S, et al. Clinical guidelines for drug-related peptic ulcer, 2020 revised edition[J]. Gut Liver, 2020, 14(6):707-726. doi: 10.5009/gnl20246 |
[11] |
LANAS A, GARCÍA-RODRÍGUEZ L A, ARROYO M T, et al. Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations[J]. Gut, 2006, 55(12):1731-1738. doi: 10.1136/gut.2005.080754 |
[12] |
BENAMOUZIG R, GUENOUN M, DEUTSCH D, et al. Review article: gastrointestinal bleeding risk with direct oral anticoagulants[J]. Cardiovasc Drugs Ther, 2022, 36(5):973-989. doi: 10.1007/s10557-021-07211-0 |
[13] |
中华心血管病杂志(网络版)编辑委员会. 口服抗栓药物相关消化道损伤防治专家共识[J]. 中华心血管病杂志(网络版), 2021, 4(1):1-8. |
[14] |
中华医学会心血管病学分会, 中国生物医学工程学会心律分会. 心房颤动诊断和治疗中国指南[J]. 中华心血管病杂志, 2023, 51(6):572-618. doi: 10.3760/cma.j.cn112148-20230416-00221 |
[15] |
中华医学会消化病学分会炎症性肠病学组, 中国炎症性肠病诊疗质量控制评估中心. 中国溃疡性结肠炎诊治指南(2023年·西安)[J]. 中华炎性肠病杂志(中英文), 2024, 8(1):33-58. |
[16] |
中华医学会消化病学分会炎症性肠病学组, 中国炎症性肠病诊疗质量控制评估中心. 中国克罗恩病诊治指南(2023年·广州)[J]. 中华炎性肠病杂志(中英文), 2024, 8(1):2-32. |
[17] |
中华医学会肠内肠外营养学分会, 中国医药教育协会炎症性肠病专业委员会. 中国炎症性肠病营养诊疗共识[J]. 中华消化病与影像杂志(电子版), 2021, 11(1):8-15. doi: 10.3877/cma.j.issn.2095-2015.2021.01.002 |
[18] |
邵雪庆. 治疗慢性结肠炎新药-愈肠颗粒的制剂及药效学研究[D]. 上海: 第二军医大学, 2018. |
[19] |
STEFFEL J, COLLINS R, ANTZ M, et al. 2021 European heart rhythm association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation[J]. Europace, 2021, 23(10):1612-1676. doi: 10.1093/europace/euab065 |